DEC 03, 2018 3:00 PM PST

Using bubbly nano-particles for chemotherapy delivery

WRITTEN BY: Heba El Wassef

We have all heard about the harsh side effects of chemotherapy that could be so difficult leading to stopping treatment. The reason behind those side effects is that chemotherapy drugs do target not only cancer cells but also the healthy cells of the body. So what if there was a way to solely target cancer cells without damaging normal cells.

Sofie, a Research Scientist at SINTEF’s Department of Biotechnology and Nanomedicine in Trondheim and a Postdoc at the Department of Physics at Norwegian University of Science and Technology (NTNU), is trying to achieve this by using nanoparticles and bubbles.

Her talk at the TEDx event was about her research on bubbly nanoparticles containing a chemotherapeutic drug, that when combined with ultrasound radiation at the target tissue, it creates a local force that disperses the nanoparticles to a broader area of cancer cells without affecting the rest of the body, which means fewer side effects and better treatment. The drug-loaded nanoparticles can be altered to when and where it will be degraded to evacuate the drug inside the cancer cells leading to its death.

This technology is promising also for brain diseases as nanoparticles can pass the blood-brain barrier into the brain cells leading to the possibility of using it with drugs for known diseases with no cure yet as Alzheimer's and Parkinson's.

Other research on the use of ultrasound with nanoparticles and the use of nanoparticles in cancer are also included.

Sources: Youtube, ScienceDirect, Hindawi

About the Author
  • A master student in Biochemistry and Molecular biology with experience in Education and Research. I am passionate about scientific research and passing my knowledge to others to help them learn about the latest in science by teaching, writing and volunteering in scientific events.
You May Also Like
OCT 05, 2020
Cancer
Fighting mitochondrial terminal exhaustion
OCT 05, 2020
Fighting mitochondrial terminal exhaustion
New findings reported in Nature Immunology highlight how the tumor microenvironment attacks the mitochondria of T l ...
OCT 26, 2020
Cancer
Investigating the Receptor Protein FPR1 in Brain Cancer
OCT 26, 2020
Investigating the Receptor Protein FPR1 in Brain Cancer
Amongst the more common targets for cancer therapies are cell surface receptors. These receptors are proteins – us ...
OCT 26, 2020
Cancer
Attacking leukemia trojan horse style
OCT 26, 2020
Attacking leukemia trojan horse style
Researchers from the Max Planck Institute of Biochemistry have developed a new approach to targeting leukemic stem cells ...
OCT 29, 2020
Cancer
Eat until you are only 70% full to reduce risk of fatty liver and liver cancer
OCT 29, 2020
Eat until you are only 70% full to reduce risk of fatty liver and liver cancer
Non-alcoholic fatty liver disease is known to be a risk factor for liver cancer because of an excess of fat accumulation ...
OCT 30, 2020
Cancer
Fighting mesothelioma with curcumin
OCT 30, 2020
Fighting mesothelioma with curcumin
Research led by investigators at Flinders University in Australia is spearheading new developments in cancer prevention ...
NOV 04, 2020
Cancer
Building a New Chemotherapy Drug
NOV 04, 2020
Building a New Chemotherapy Drug
For decades, modern medicine has relied on chemists’ work to produce compounds that could one day be used as a dru ...
Loading Comments...